The effect of tiotropium in COPD complicated with asthma
T. Iwanaga, E. Naito, H. Ichihashi, S. Kitaguchi, Y. Ikeda, A. Sano, R. Sato, F. Tsuji, T. Miyara, H. Sano, M. Muraki, H. Kubo, Y. Tohda (Osakasayama, Osaka, Japan)
Source: Annual Congress 2007 - New insights into the treatment of COPD
Session: New insights into the treatment of COPD
Session type: Thematic Poster Session
Number: 3588
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Iwanaga, E. Naito, H. Ichihashi, S. Kitaguchi, Y. Ikeda, A. Sano, R. Sato, F. Tsuji, T. Miyara, H. Sano, M. Muraki, H. Kubo, Y. Tohda (Osakasayama, Osaka, Japan). The effect of tiotropium in COPD complicated with asthma. Eur Respir J 2007; 30: Suppl. 51, 3588
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The effect of tiotropium in the treatment of patients with COPD Source: Annual Congress 2010 - COPD: management Year: 2010
The effect of inhaler switching on asthma and COPD patients Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018
The effect of bronchiectasis on asthma exacerbations Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012
Additive benefits of tiotropium in asthmatics and in patients with asthma complicated chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 546s Year: 2007
The effect of formoterol in elderly COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 122s Year: 2005
The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015
Formoterol given either alone or together with tiotropium, reduces the rate of exacerbations in stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006
Bronchodilator treatment for asthma and COPD Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010
Bronchodilator efficacy of tiotropium in patients with mild COPD Source: Eur Respir J 2006; 28: Suppl. 50, 616s Year: 2006
QVA149 improves lung function and reduces exacerbations compared to tiotropium in patients with severe-to-very severe COPD: The SPARK study Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013
FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013
The direct costs of exacerbations in COPD and the effect of cilomilast treatment Source: Eur Respir J 2002; 20: Suppl. 38, 245s Year: 2002
Comparison of fluticasone, roflumilast and tiotropium in a model of influenza-induced acute COPD exacerbation Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013
Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006
Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Dual bronchodilation with once-daily QVA149 improves lung function and reduces exacerbations in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
Budesonide/formoterol added to tiotropium improves exacerbations and exacerbation-related antibiotic use in patients with COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Dual bronchodilation with once-daily QVA149 reduces exacerbations, improves lung function and health status versus glycopyrronium and tiotropium in severe-to-very severe COPD patients: The SPARK study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013
Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001
Ceruloplasmine efficacy in patients with asthma exacerbations Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011